Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CT-0525 |
Trade Name | |
Synonyms | CT0525|CT 0525 |
Drug Descriptions |
CT-0525 are monocytes engineered to express a chimeric antigen receptor (CAR) targeting ERBB2 (HER2), which potentially inhibit tumor growth (Journal for ImmunoTherapy of Cancer 2022;10, Suppl_2). |
DrugClasses | HER2 (ERBB2) Immune Cell Therapy 6 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CT-0525 | CT-0525 | 0 | 1 |